Supernus Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.

CEO

Jack A. Khattar

CEOJack A. Khattar

Employees

674

Employees674

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2005

Founded2005

Employees

674

Employees674

SUPN Key Statistics

Market cap

3.09B

Market cap3.09B

Price-Earnings ratio

48.18

Price-Earnings ratio48.18

Dividend yield

—

Dividend yield—

Average volume

845.32K

Average volume845.32K

High today

$57.33

High today$57.33

Low today

$54.21

Low today$54.21

Open price

$56.33

Open price$56.33

Volume

890.92K

Volume890.92K

52 Week high

$57.65

52 Week high$57.65

52 Week low

$29.16

52 Week low$29.16

SUPN News

TipRanks 5d

Supernus Pharmaceuticals’ Real-World Study on ONAPGOTM: A Closer Look

Supernus Pharmaceuticals ((SUPN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 5d

Supernus Pharmaceuticals Advances ADHD Treatment Study in Young Children

Supernus Pharmaceuticals ((SUPN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.